全文获取类型
收费全文 | 5542篇 |
免费 | 448篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 49篇 |
儿科学 | 201篇 |
妇产科学 | 141篇 |
基础医学 | 778篇 |
口腔科学 | 273篇 |
临床医学 | 475篇 |
内科学 | 1131篇 |
皮肤病学 | 125篇 |
神经病学 | 506篇 |
特种医学 | 262篇 |
外国民族医学 | 1篇 |
外科学 | 848篇 |
综合类 | 39篇 |
预防医学 | 327篇 |
眼科学 | 55篇 |
药学 | 303篇 |
中国医学 | 9篇 |
肿瘤学 | 483篇 |
出版年
2023年 | 28篇 |
2022年 | 46篇 |
2021年 | 129篇 |
2020年 | 97篇 |
2019年 | 142篇 |
2018年 | 172篇 |
2017年 | 113篇 |
2016年 | 129篇 |
2015年 | 160篇 |
2014年 | 194篇 |
2013年 | 232篇 |
2012年 | 298篇 |
2011年 | 288篇 |
2010年 | 200篇 |
2009年 | 175篇 |
2008年 | 216篇 |
2007年 | 236篇 |
2006年 | 211篇 |
2005年 | 221篇 |
2004年 | 197篇 |
2003年 | 206篇 |
2002年 | 203篇 |
2001年 | 143篇 |
2000年 | 145篇 |
1999年 | 131篇 |
1998年 | 91篇 |
1997年 | 95篇 |
1996年 | 82篇 |
1995年 | 77篇 |
1994年 | 65篇 |
1993年 | 63篇 |
1992年 | 103篇 |
1991年 | 99篇 |
1990年 | 100篇 |
1989年 | 99篇 |
1988年 | 86篇 |
1987年 | 101篇 |
1986年 | 79篇 |
1985年 | 74篇 |
1984年 | 46篇 |
1983年 | 43篇 |
1982年 | 22篇 |
1981年 | 37篇 |
1979年 | 42篇 |
1978年 | 33篇 |
1977年 | 25篇 |
1973年 | 26篇 |
1972年 | 23篇 |
1968年 | 20篇 |
1967年 | 25篇 |
排序方式: 共有6006条查询结果,搜索用时 15 毫秒
91.
Gupta V Yesilbursa D Huang WY Aggarwal K Gupta V Gomez C Patel V Miller AP Nanda NC 《Echocardiography (Mount Kisco, N.Y.)》2008,25(2):217-227
BACKGROUND: Patent foramen ovale (PFO) is a well-recognized risk factor for ischemic strokes. The true prevalence of PFO among stroke patients is still under debate. Transesophageal echocardiography (TEE) is the "gold standard" in diagnosing PFO but the physiology requires right-to-left atrial shunting. In this report, we evaluate the prevalence of PFO in a diverse group of ischemic stroke patients studied by TEE. METHODS: TEE of 1,663 ischemic stroke patients were reviewed for cardiac source of embolism, including PFO and atrial septal aneurysm (ASA). Agitated saline bubble injection was performed to look for right to left atrial shunting. Success of maneuvers to elevate right atrial pressure (RAP) was noted by looking at the atrial septal bulge. RESULTS: Among 1,435 ischemic stroke patients analyzed, the presence or absence of PFO could not be determined in 32.1% because bulging of the septum could not be demonstrated in patients with negative contrast study despite aggressive maneuvers to elevate RAP. Of the remaining 974 patients, 294 patients (30.2%) had a PFO. The mean age was 61.5 years in both groups, with a bimodal distribution of PFO and the highest prevalence occurring in < or =30-year-old group. Prevalence of PFO was similar in men (32.4%) and women (28.15%, P = 0.15); and in Caucasian (32.1%) and African American (27.7%; P = 0.15). ASA was present in 2.02% and hypermobile septum in 2.49% of the 1,435 patients. PFO was seen in 79.3% of the patients with ASA. CONCLUSION: Successful elevation of RAP cannot be achieved in a significant number of patients undergoing TEE and determination of PFO may be difficult. In our series, the true prevalence of PFO among ischemic stroke patients was 30.2% taking into account only those patients who showed no shunting despite bulging of the atrium septum into the left atrium (PFO absent group) during the contrast study. There was no gender or racial difference in the prevalence of PFO, but there was a bimodal distribution in prevalence with age. 相似文献
92.
Mercè Cladellas Jordi Bruguera Josep Comín Joan Vila Elisabeth de Jaime Julio Martí Miquel Gomez 《European heart journal》2006,27(9):1093-1099
AIMS: To assess the level of pre-operative haemoglobin (HB) as a risk marker for morbidity and mortality in the early post-operative period of patients who underwent elective valve replacement. METHODS AND RESULTS: Between January 1998 and March 2004, clinical and outcomes data were collected for the 201 patients who had elective valve replacement. For each gender, the criterion to choose the best cut-off point was that which achieved the maximum likelihood after several General Additive Model models performed in a Bootstrap procedure. The best cut-off point obtained for pre-operative HB was 12 g/dL. Overall peri-operative mortality (deaths occurring during hospital period or within 30 days) was 9.5%. After adjusting well-known independent pre-operative risk factors for operative mortality, pre-operative HB <12 g/dL was identified as an independent predictor for in-hospital mortality (OR, 3.23; 95% CI, 1.09-9.55; P = 0.03). Also adjusting for EuroScore, pre-operative HB remained significant (OR, 3.64; 95% CI, 1.32-10.06; P = 0.01). The same model was applied to post-operative morbidity, and pre-operative HB <12 g/dL was identified as an independent predictor with and without EuroScore (OR, 4.67; 95% CI, 2.03-10.71; P < 0.001), (OR, 5.18; 95% CI, 2.18-12.3; P < 0.001), respectively. CONCLUSION: In patients undergoing elective valve replacement pre-operative HB <12 g/dL is a risk marker of in-hospital mortality and serious adverse outcomes. 相似文献
93.
94.
High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancy 总被引:2,自引:1,他引:2
Brown RA; Herzig RH; Wolff SN; Frei-Lahr D; Pineiro L; Bolwell BJ; Lowder JN; Harden EA; Hande KR; Herzig GP 《Blood》1990,76(3):473-479
Seventy-five patients with resistant acute leukemia or lymphoma received high-dose cyclophosphamide and etoposide to explore the activity of this combination in resistant hematologic malignancies, and to determine the maximum doses of these drugs that can be combined without bone marrow transplantation. Etoposide was administered over 29 to 69 hours by continuous infusion corresponding to total doses of 1.8 g/m2 to 4.8 g/m2. Cyclophosphamide, 50 mg/kg/d, was administered on 3 or 4 consecutive days total 150 to 200 mg/kg ideal body weight). At all dose levels myelosuppression was severe but reversible. Mucosal toxicity was dose-limiting with the maximum tolerated dose level combining etoposide 4.2 g/m2 with cyclophosphamide 200 mg/kg. Continuous etoposide infusion produced stable plasma levels that were lower than would be achieved after administration by short intravenous infusion, and this could explain our ability to escalate etoposide above the previously reported maximum tolerated dose. There were 28 complete (35%) and 12 partial (16%) responses. Median duration of complete response (CR) was 3.5 months (range 1.1 to 20+). Seventeen of 40 patients (42%) with acute myelogenous leukemia (AML) achieved CR, including 6 of 20 (30%) with high-dose cytosine arabinoside resistance. We conclude that bone marrow transplantation is not required after maximum tolerated doses of etoposide and cyclophosphamide. This regimen is active in resistant hematologic neoplasms, and the occurrence of CR in patients with high-dose cytosine arabinoside-resistant AML indicates a lack of complete cross-resistance between these regimens. 相似文献
95.
Dr. Carlos Defilippi MD Nelson Mamani MD Elsa Gomez 《Digestive diseases and sciences》1987,32(2):171-176
Duodenogastric reflux was studied in fasting dogs with gastric and duodenal cannulae, by means of recovery from the gastric cannula of phenol red infused into the duodenum and bile acids recovered from the gastric cannula. Simultaneously, antropyloric and intestinal motility was studied in order to establish a relationship between motility and duodenogastric reflux. A different pattern of duodenogastric reflux was observed, depending on the method utilized. While a significantly higher reflux was observed during phase II in bile acid studies, an irregular pattern not related to the different phases of the interdigestive motor complex was observed in experiments with phenol red. Antral motility estimated by an antral motility index showed a statistically significant correlation with DGR estimated by both methods. Pyloric pressure and intestinal motility did not show a correlation with DGR. We concluded that the results obtained in studying duodenogastric reflux depend on the method used. The main factor related to increased duodenogastric reflux was the decreased antral motility. 相似文献
96.
Benjamin W. Dean Sarah N. Hewitt Morgan C. Begos Angela Gomez Locksley L. McV. Messam 《Transfusion and apheresis science》2018,57(1):40-45
Objectives
To estimate the associations of nationality, university program, donation history and gender, with blood donation barriers experienced by non-donating students on the day of a campus blood drive. This project focused particularly on nationality and the effect of the different blood donation cultures in the students' countries of origin.Methods
A retrospective cohort study of 398 North American and Caribbean university students was conducted at St. George's University, Grenada, in 2010. Data were collected from non-donating students on campus while a blood drive was taking place. Log-binomial regression was used to estimate associations between the exposures of interest and donation barriers experienced by the students.Results
North American (voluntary blood donation culture) students were more likely than Caribbean (replacement blood donation culture) students to experience “Lack of Time” (relative risk (RR)?=?1.57; 95% confidence interval (CI): 1.19–2.07) and “Lack of Eligibility” (RR?=?1.55; 95% CI: 1.08–2.22) as barriers to donation. Conversely, Caribbean students were a third as likely to state “Lack of Incentive” (RR?=?0.32; 95% CI: 0.20–0.50), “Fear of Infection” (RR?=?0.35; 95% CI: 0.21–0.58), and “Fear of Needles” (RR?=?0.32; 95% CI: 0.21–0.48) were barriers than North American students.Conclusions
University students from voluntary blood donation cultures are likely to experience different barriers to donation than those from replacement cultures. Knowledge of barriers that students from contrasting blood donation systems face provides valuable information for blood drive promotion in university student populations that contain multiple nationalities. 相似文献97.
Theresa H.?M. Keegan Allison W. Kurian Kathleen Gali Li Tao Daphne Y. Lichtensztajn Dawn L. Hershman Laurel A. Habel Bette J. Caan Scarlett L. Gomez 《American journal of public health》2015,105(5):938-946
Objectives. We examined the combined influence of race/ethnicity and neighborhood socioeconomic status (SES) on short-term survival among women with uniform access to health care and treatment.Methods. Using electronic medical records data from Kaiser Permanente Northern California linked to data from the California Cancer Registry, we included 6262 women newly diagnosed with invasive breast cancer. We analyzed survival using multivariable Cox proportional hazards regression with follow-up through 2010.Results. After consideration of tumor stage, subtype, comorbidity, and type of treatment received, non-Hispanic White women living in low-SES neighborhoods (hazard ratio [HR] = 1.28; 95% confidence interval [CI] = 1.07, 1.52) and African Americans regardless of neighborhood SES (high SES: HR = 1.44; 95% CI = 1.01, 2.07; low SES: HR = 1.88; 95% CI = 1.42, 2.50) had worse overall survival than did non-Hispanic White women living in high-SES neighborhoods. Results were similar for breast cancer–specific survival, except that African Americans and non-Hispanic Whites living in high-SES neighborhoods had similar survival.Conclusions. Strategies to address the underlying factors that may influence treatment intensity and adherence, such as comorbidities and logistical barriers, should be targeted at low-SES non-Hispanic White and all African American patients.Breast cancer is the most common cancer among women in the United States, and it is the second leading cause of cancer death.1 Despite significant improvements in breast cancer survival from 1992 to 2009,1,2 racial/ethnic and socioeconomic survival disparities have persisted.3,4 African American women have consistently been found to have worse survival after breast cancer,3,5–11 Hispanic women have worse or similar survival,3,9,11,12 and Asian women as an aggregated group have better or similar survival3,9,11,12 than do non-Hispanic White women. Underlying factors thought to contribute to these racial/ethnic disparities include differences in stage at diagnosis,8,12,13 distributions of breast cancer subtypes,14–16 comorbidities,12,13,17 access to and utilization of quality care,13,18 and treatment.12,13Numerous studies also have found poorer survival after breast cancer diagnosis among women residing in neighborhoods of lower socioeconomic status (SES).6,9,19,20 Research has shown that inadequate use of cancer screening services, and consequent late stage diagnosis and decreased survival, contribute to the SES disparities.21,22 Similar to racial/ethnic disparities, SES disparities have been attributed to inadequate treatment and follow-up care and comorbidities.18 Previous population-based studies have continued to observe racial/ethnic survival disparities after adjusting for neighborhood SES, but these studies have not considered the combined influence of neighborhood SES and race/ethnicity.3,9,11,12,23 These disparities may remain because information on individual-level SES, health insurance coverage, comorbidities, quality of care, and detailed treatment regimens have typically not been available.3,8,9,11,13 Even among studies using national Surveillance Epidemiology and End Results–Medicare linked data, in which more detailed information on treatment and comorbidities are available among some patients aged 65 years and older, survival disparities have remained.12,23,24 However, not all data on medical conditions and health care services are captured in Medicare claims, including data on Medicare beneficiaries enrolled in HMOs (health maintenance organizations).25,26Using electronic medical records data from Kaiser Permanente Northern California (KPNC) linked to data from the population-based California Cancer Registry (CCR), we recently reported that chemotherapy use followed practice guidelines but varied by race/ethnicity and neighborhood SES in this integrated health system.27 Therefore, to overcome the limitations of previous studies and address simultaneously the multiple social28 and clinical factors affecting survival after breast cancer diagnosis, we used the linked KPNC–CCR database to determine whether racial/ethnic and socioeconomic differences in short-term overall and breast cancer–specific survival persist in women in a membership-based health system. Our study is the first, to our knowledge, to consider the combined influence of neighborhood SES and race/ethnicity and numerous prognostic factors, including breast cancer subtypes and comorbidities, thought to underlie these long-standing survival disparities among women with uniform access to health care and treatment. 相似文献
98.
Effectiveness of an intensive intervention to improve lifestyles in people with intermediate cardiovascular risk (DATE study): Study protocol for a randomized controlled trial 下载免费PDF全文
99.
Well crystalline gold nanoparticles (AuNPs) of different sizes were fabricated using sundried Coffea arabica seed (CAS) extract at room temperature by controlling the pH of the green extract. The size, shape and crystallinity of the nanoparticles have been studied using electron microscopy and X-ray diffraction. The presence of phenolic groups (revealed through FT-IR studies) from the CAS extract are responsible both for the reduction of Au ions and stabilization of the formed AuNPs. The efficiency of the CAS extract mediated green synthesis technique for the production of AuNPs has been compared to the conventional chemical Turkevich technique, which not only uses a toxic reductant such as NaBH4, but also operates around the boiling point of water. It has been observed that the CAS extract mediated synthesis process produces relatively bigger AuNPs at similar pH values of the reaction mixture in comparison to the AuNPs produced in the Turkevich process. Although the AuNPs synthesized using CAS extract are relatively larger and polydisperse in nature, their catalytic efficiencies for the degradation of an aromatic nitro compound (4-nitrophenol) are found to be comparable to the chemically fabricated AuNPs. Probable mechanisms associated with the formation of AuNPs and their size control in the CAS extract mediated green synthesis process have been discussed.Size dependent catalytic activity of AuNPs synthesized at room temperature from Coffea arabica seed extract. 相似文献
100.
Gomez NN Fernandez MR Zirulnik F Gil E Scardapane L Ojeda MS Gimenez MS 《Experimental lung research》2003,29(7):485-502
Few studies are available about the role of dietary zinc (Zn) in respiratory diseases. Adult male rats were divided into 2 groups and fed respectively a moderate Zn-deficient diet and a Zn-adequate control diet. In lung tissue at 2 months, thiobarbituric acid-reactive species (TBARS), total glutathione, glutathione disulfide, protein carbonyls, metallothionein, and the activities of glutathione peroxidase (GPx), catalase, CuZn-superoxide dismutase (CuZnSOD) and glucose-6-phosphate dehydrogenase (G-6-PDH) were increased, but protein thiols decreased. In lung tissue at 4 months, TBARS, metallothionein, and the activities of CuZnSOD, Mn-superoxide dismutase (MnSOD) increased. The activities GPx, catalase, G-6-PDH were lower than control group. The changes were accompanied by histological alterations in Zn-deficient lung. The results provide evidence of the pro-oxidative effects of Zn-deficiency in lung, and suggest that the time of treatment play a key role in determining lung susceptibility to oxidative stress. 相似文献